HeartWare employs approximately 70 personnel. Set out below are...

HeartWare employs approximately 70 personnel. Set out below are brief biographies of the Company's senior executives.

Douglas Godshall
Managing Director, Chief Executive Officer

Doug joined HeartWare as Chief Executive Officer in September 2006. An experienced medical device executive, Doug has overall responsibility for developing and executing HeartWare's strategic plan and for delivering key corporate, operational and financial objectives.

Prior to joining HeartWare Doug spent over 16 years at Boston Scientific, most recently as President of the Vascular Surgery Division. He previously spent five years as Vice President, Business Development where he was instrumental in developing the acquisition strategies for the cardiology, electrophysiology, neuroradiology and vascular surgery divisions. He led the negotiation and structuring of over 70 transactions and represented Boston Scientific on the Boards of 11 companies. Prior to assuming the Business Development position, he was Director of Marketing for Boston Scientific's Urology Division, where he helped to build global sales to over US$150 million.

Doug has established and led executive teams through the clinical development, market launch and commercial rollout of a range of medical devices. He has a track record of identifying and successfully executing substantial business partnerships and brings to HeartWare a breadth of financial, strategic and operational relationships. avid McIntyre
Chief Financial Officer, Company Secretary

David joined HeartWare shortly after the IPO. He is an experienced medical device industry executive with both development-stage and large corporate credentials.

Prior to joining HeartWare, David was the Chief Financial Officer and General Counsel to another ASX-listed medical device company. He has previously served as a corporate and commercial law specialist in major international law firms, advising some of the world's largest corporations in various areas including mergers and acquisitions, corporate fundraising and securities law. He has also held senior financial roles in multinational companies, among them Rio Tinto.

David holds a Bachelor of Economics, majoring in accounting from the University of Sydney and a Bachelor of Laws from the University of Technology, Sydney. He is admitted as a Solicitor of the Supreme Court of New South Wales and is a member of the Law Society of New South Wales and CPA Australia.

Dozier Rowe
Chief Operating Officer

Dozier joined HeartWare as Chief Operating Officer in April 2006. He has primary responsibility for managing and leading all internal operational functions of the business.

Dozier brings to HeartWare over 20 years of experience in the medical device industry, having held senior positions at Boston Scientific Corporation, St Jude Medical Inc. and Baxter Healthcare Corporation. He has worked with a variety of Class III implantable medical devices with responsibility across all elements of manufacturing, quality control, regulatory affairs, materials management, supply chain and operations. He previously held the position of Vice President and General Manager, Operations at Boston Scientific's Miami operations centre, where he had responsibility for over 1,000 staff and a budget in excess of USD100 million per year.

Jeffrey A. LaRose
Chief Scientific Officer

Jeff has been the driving force behind the development of HeartWare's technologies for the past eight years. He is responsible for all aspects of the design of the HeartWare HVADTM System and he leads the development of HeartWare's device miniaturisation program.

Jeff has over 20 years experience in hydraulic technology development including roles with AEA Technology Engineering Software and Bab+ock and Wilcox. He holds a Master of Science in Mechanical Engineering.

Jennifer Foley
Vice President, Clinical and Regulatory Affairs

Jennifer has responsibility for the design and execution of HeartWare's clinical trial program and regulatory plan.

Jennifer has extensive experience in clinical and regulatory activities. Prior to joining HeartWare in January 2006, she held the position of Vice-President, Clinical Sciences, Clinical Program Management and Operations at Boston Scientific Corporation. As one of the most senior executives within Boston Scientific's clinical affairs organization, she was responsible for overseeing the execution of clinical trials across 9 of the company's divisions. Prior to joining Boston Scientific in 2002, Jennifer was responsible for managing major trials with The Medicines Company and Glaxo (now GlaxoSmithKline). She previously spent 5 years in leadership positions at Parexel International Corporation, one of the world's largest contract research organizations.

Jane Reedy
Vice President, Sales and Marketing

Jane has over 20 years experience in directing clinical affairs, sales and marketing in the circulatory assist device industry.

She previously served as the Director of Clinical Services, Director of Sales and Director of Market Development for Thoratec Corporation. She has developed clinical and regulatory strategies for complex medical products, designed and directed multi-centre studies, formulated and executed global sales and marketing strategies and managed a network of distributors and clinical specialists worldwide.
Jane has a Master of Science in nursing from St. Louis University and has served as Department Head of Cardiothoracic Services at St. Louis University Hospital.

Barry M. Yomtov
Vice President, Product Development

Barry joined HeartWare in August 2006. He is responsible for the design and development of new products, with a particular focus on HeartWare's electronics programs.

Barry has over 28 years experience in the medical device industry specializing in Class III implantable medical devices. Prior to joining HeartWare, Barry has held senior management positions at MicroCHIPS, Inc, Abiomed, Inc., and InControl, Inc. He also spent 10 years at Cordis Corp. in the design and development of pacemakers, neurostimulators and defibrillators. Barry received a Masters of Engineering in Biomedical Engineering from Rensselaer Polytechnic Institute. He has 9 patents issued, 2 patents pending, plus 10 publications in the field of medical devices.

Ramon Augusto Paz
Director, Quality Assurance

Ramon joined HeartWare Inc. as Director of Quality Assurance in October 2004. He has primary responsibility for establishing and managing the company's Quality Management System.

Ramon has over 23 years of multifunctional experience in the medical device industry across Quality, Manufacturing, Engineering, Regulatory and Clinical organizations. He began his career with Cordis Corporation, where he spent 15 years in a range of progressively more senior positions across the Quality, Manufacturing and Product Development groups. In 1998 Ramon joined World Medical, a start-up company which was later acquired by MedtronicAVE, where Ramon was Head of Quality, with expanded responsibility for managing the regulatory and clinical groups responsible for the clinical study of the TALENT stent graft.

Howard Leibman
Director, Corporate Development

Howard joined HeartWare soon after the Company's IPO in January 2005. Based at HeartWare's corporate head office in Sydney, Australia, he is responsible for financial strategy, investor relations and corporate communications.

Prior to joining HeartWare, Howard was Associate Director at Emerging Growth Capital, a specialist life sciences investment house. He advised on a number of successful Initial Public Offerings, private capital raisings and other corporate transactions and played a key role in HeartWare's capital raising and listing on the ASX.

Howard's previous roles include Executive Director at Aeris Technologies, a company listed on the ASX, and Design Engineer at General Electric Company. He holds a Bachelor of Engineering and a Bachelor of Arts from the University of New South Wales and an MBA from the Australian Graduate School of Management and London Business School.